Peer Comparison
| Company | Market Price | MCAP(Cr) | P/B | P/E | EPS | ROE |
|---|---|---|---|---|---|---|
| LAURUSLABS | 376.35(-1.2%) | 20,426 | 5.1 | 55.5 | 23.0 | 21.6 |
| PEL | 936.25(-0.4%) | 21,125 | 0.7 | 5.4 | 11.7 | 30.0 |
| GLENMARK | 779.05(0.0%) | 21,909 | 2.3 | 0.0 | 9.2 | 4.1 |
| SANOFI | 8175.2(0.9%) | 18,653 | 22.7 | 119.6 | 59.8 | 40.8 |
| PFIZER | 4035(-0.4%) | 18,540 | 5.3 | 135.2 | 27.6 | 20.6 |
| JBCHEPHARM | 1476(0.3%) | 22,755 | 8.4 | 46.8 | 17.8 | 14.9 |
| SUVENPHAR | 669(-0.4%) | 17,175 | 8.9 | 39.8 | 33.4 | 25.2 |
| AJANTPHARM | 1966.85(-0.1%) | 24,666 | 7.1 | 37.4 | 22.6 | 17.7 |
| APLLTD | 761.5(1.3%) | 14,744 | 3.3 | 27.7 | 7.2 | 7.1 |
| NATCOPHARM | 780.2(-1.7%) | 14,184 | 2.7 | 12.6 | 18.1 | 15.7 |
| ERIS | 919.55(-0.7%) | 12,361 | 5.1 | 32.1 | 17.3 | 18.3 |
| GLAXO | 1692(-0.3%) | 28,730 | 18.7 | 44.4 | 16.5 | 5.5 |
| ASTRAZEN | 4832.65(1.8%) | 11,998 | 18.3 | 78.5 | 24.5 | 18.1 |
| BIOCON | 243.1(1.0%) | 28,898 | 1.5 | 58.0 | 16.1 | 18.0 |
| IPCALAB | 1144.6(0.4%) | 28,982 | 4.7 | 58.9 | 11.8 | 8.9 |
